HomeNewsBusinessAnnouncementsAurobindo Pharma receives USFDA final approval for Valsartan and Hydrochlorothiazide tablets
Trending Topics

Aurobindo Pharma receives USFDA final approval for Valsartan and Hydrochlorothiazide tablets

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Valsartan and Hydrochlorothiazide Tablets USP, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg and 320mg/25mg (ANDA 202519). The product is ready for launch.

March 22, 2013 / 13:28 IST
Story continues below Advertisement

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated March 22, 2013, titled "Aurobindo Pharma receives USFDA final approval for Valsartan and Hydrochlorothiazide Tablets".

The company has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Valsartan and Hydrochlorothiazide Tablets USP, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg and 320mg/25mg (ANDA 202519). The product is ready for launch.Source : BSE

Read all announcements in Aurobindo Pharm

Story continues below Advertisement
first published: Mar 22, 2013 01:28 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!